LeukoSCAN ImmuRAID-MN3 antibody fragment targeting the surface glycoprotein NCA-90 on neutrophils data

Three separate centers involved in a Phase III trial reported results with IMMU's agent versus the

Read the full 164 word article

How to gain access

Continue reading with a
two-week free trial.